Joint Muscle Medical Care and Research Institute

“Wherever the art of Medicine is loved, there is also a love of Humanity. ” - Hippocrates

**Currently Open for Enrollment**

Protocol: AstraZeneca D3461C00005 – A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 3 Study Evaluating the Efficacy and Safety of Two Doses of Anifrolumab in Adult Subjects with Active Systemic Lupus Erythematosus


Download Inform Consent and review:


For more information visit:

www.whatistulip.com 

or

https://clinicaltrials.gov/ct2/show/NCT02446912?term=d3461c00005&rank=1

**Enrollment is Closed**


IM-128-027 SLE:  A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of BMS-931699 vs. Placebo on a Background of Limited Standard of Care  in the Treatment of Subjects with Active Systemic Lupus Erythematosus


For more information visit:

https://clinicaltrials.gov/ct2/show/NCT02265744?term=IM-128-027&rank=1

**Enrollment is Open**


BASE –HGS1006-C1113 - A randomized, double blinded, placebo controlled 52-week study to assess adverse events of special interest in adults with active, autoantibody-positive Systemic Lupus Erythematosus receiving Belimumab


*We are currently open and still enrolling patients. *


For more information visit:

https://clinicaltrials.gov/ct2/show/NCT01705977?term=HGS1006-C1113&rank=1


**Enrollment is Closed**

AUR-VCS-2012-01: A randomized, controlled double blind study comparing the efficacy and safety of voclosporin (23.7 mg BID, or 39.5 mg BID) with placebo in achieving remission in patients with active lupus nephritis.


For more information visit:

https://clinicaltrials.gov/ct2/show/NCT02141672?term=AUR-VCS-2012-01&rank=1

**Currently Open for Enrollment**


Protocol: Enbrel 20130207- A Multicenter Double-Blind, Randomized Controlled Study of Etanercept and Methotrexate in Combination or as Monotherapy in Subjects With Psoriatic Arthritis


For more information visit:

https://clinicaltrials.gov/ct2/show/NCT02376790?term=20130207&rank=1

**Currently Open for Enrollment**

Protocol: 20110186 RA– A Randomized Withdrawal Double-blind Study of Etanercept Monotherapy Compared to Methotrexate Monotherapy for Maintenance of Remission in Subjects With Rheumatoid Arthritis


For More Information visit:

https://clinicaltrials.gov/ct2/show/NCT02373813?term=20110186&rank=1